Efficacy of Anastrozole and Fulvestrant in Patients With ER Positive, HER2 Negative, Operable Breast Cancer
Clinical trial NCT00629616 · COMPLETED
Trial details
- NCT number
- NCT00629616
- Sponsor
- UNICANCER
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-10-01
- Primary completion
- 2015-06-01
- Enrollment
- 116
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.